Painceptor Pharma announces collaboration with Argenta Discovery

03-May-2006

PainCeptor Pharma Corp. announced that it has entered into a development collaboration with Argenta Discovery Ltd., a contract and respiratory drug development company. Under the terms of the agreement, scientists from the two companies will exploit Argenta's expertise in computer-aided drug design (CADD) and medicinal chemistry to accelerate PainCeptor's ASIC (acid-sensing ion channel) development program for pain therapeutics, targeting these sensory mechanisms which are associated with a variety of pain-related conditions, including cancer and arthritis.

Financial terms of the deal were not disclosed, but the agreement does provide options to expand the relationship.

Other news from the department business & finance

Most read news

More news from our other portals

All FT-IR spectrometer manufacturers at a glance